Petros Pharmaceuticals has acquired 1 company, including 1 in the last 5 years. A total of 1 acquisition came from private equity firms.
Petros Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
1185 Avenue of the Americas Suite 249,
New York, New York
10036
United States,
(973) 242-0005
www.petrospharma.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2020-05-18 |
Metuchen Pharmaceuticals · Life Science
Freehold, New Jersey · www.metuchenpharma.com Metuchen Pharmaceuticals is a men’s health-focused specialty pharmaceutical company. The company identifies, acquires, develops and commercializes products that have significant clinical advantages and patent protection. Metuchen has a full range of commercial capabilities including sales, marketing regulatory and medical affairs, finance, trade relations, pharmacovigilance, managed care customer management, manufacturing and distribution. Metuchen Pharmaceuticals was founded in 2016 and is based in Freehold, New Jersey. Advisor: Morgan Lewis |
- | Merger |
Petros Pharmaceuticals
|
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
